Chardan Healthcare Acquisition Corp.

Chardan Healthcare Acquisition Corp. is a New York-based investment banking firm focusing on the healthcare and biotech sectors, specializing in capital market navigation and providing strategic financial services. Chardan Healthcare Acquisition Corp. operates as an investment banking firm serving the healthcare and biotech industries.

Founded in 2002 in New York, US, the firm has evolved its business strategy to include the management of special purpose acquisition companies (SPACs). Kerry Propper, one of the founders, has a history of involvement in investment and advisory roles, contributing to the firm’s strategic direction under the leadership of CEO Steven Urbach. Chardan Capital Markets specializes in investment banking services tailored to the healthcare and biotech sectors. They provide a comprehensive range of services including underwriting, advisory, and management of SPACs, along with strategic advice in mergers and acquisitions and integrated capital markets.

Chardan emphasizes support for innovative companies delivering breakthroughs in healthcare technologies by securing necessary funding through options like equity, debt, convertible funding, and initial public offerings (IPOs). Their client base includes biotech firms, healthcare technology developers, and investors engaged with disruptive technologies, operating across global markets with a focus on North America, Europe, and Asia. Chardan Capital Markets generates revenue through a structured transaction model, primarily engaging in B2B relationships with healthcare and biotech companies. The firm earns fees from underwriting services during SPAC transactions and advisory fees from M&A deals.

Clients typically compensate for these services via fixed fee arrangements or a percentage of the capital raised, ensuring aligned incentives. Chardan’s flagship offerings, especially related to SPACs, attract various institutional investors and private equity firms looking for innovative financing solutions.